Immunoprecise Antibodies Ltd expected to post a loss of 20 cents a share - Earnings Preview

Mindwalk Holdings

08/09/2023 13:38

* Immunoprecise Antibodies Ltd  IPA.OQ   IPA.O  is expected
to show a rise in quarterly revenue when it reports  results on
September 12 (estimated). 
    * The Victoria British Columbia-based  company is expected
to
report  a 14.1% increase in revenue to C$5.35 million from
C$4.69 million a year ago, according to the mean estimate from 2
analysts, based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Immunoprecise
Antibodies
Ltd is for a loss of 20 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for
Immunoprecise
Antibodies Ltd is $8​, above​ its last closing price of $2.00.
​​​

This summary was machine generated September 8 at 12:38 GMT. 
All figures in Canadian dollars  unless otherwise stated